Arca
Skip to content
Tools
Tools

SNAP25: Synaptosomal-associated protein 25

t-SNARE involved in the molecular regulation of neurotransmitter release.

  • Drugs that act on it: 8
  • Approved: 7
  • In phases 1 to 3: 1
  • Sponsors: 7

Who is on it, and how far along

Every drug ChEMBL records acting on SNAP25, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 2
  • Other 6

Approved7

  • Abobotulinumtoxina
  • Daxibotulinumtoxina
  • Onabotulinumtoxina
  • Botulinum toxin type a
  • Incobotulinumtoxina
  • Prabotulinumtoxin a
  • Letibotulinumtoxina

Phase 31

  • Trenibotulinumtoxine

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      • AEON Biopharma, Inc.113%
      • Medy-Tox113%

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 4 of 8 act as: Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor; the rest name their own mechanism.
      AbobotulinumtoxinaBoxed warningApprovedIpsenOtherInhibitor180
      DaxibotulinumtoxinaApprovedRevance TherapeuticsOtherInhibitor180
      OnabotulinumtoxinaBoxed warningApprovedAbbVieOtherInhibitor180
      Botulinum toxin type aBoxed warningApprovedMedy-ToxProtein or peptideHydrolytic enzymeSynaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme178
      IncobotulinumtoxinaBoxed warningApprovedMerz GroupOtherInhibitor43
      Prabotulinumtoxin aBoxed warningApprovedAEON Biopharma, Inc.OtherProteolytic enzymeSynaptosomal nerve-associated protein 25 (SNAP-25) proteolytic enzyme1
      LetibotulinumtoxinaApprovedHugelOtherHydrolytic enzymeSynaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme0
      TrenibotulinumtoxinePhase 3AbbVieProtein or peptideHydrolytic enzymeSynaptosomal nerve-associated protein 25 (SNAP-25) hydrolytic enzyme3

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 18 in all, from ClinicalTrials.gov.
      EndoFLIP-Guided Initial Management of Esophagogastric Junction Outflow ObstructionAbobotulinumtoxina, Daxibotulinumtoxina, Onabotulinumtoxina, Botulinum toxin type aNot applicableNot yet recruitingHospital Clinic of BarcelonaNov 10, 2026
      Can TrenibotulinumtoxinE Reverse OnabotulinumtoxinA Effect in Treating Lateral Canthal Lines?Abobotulinumtoxina, Daxibotulinumtoxina, Onabotulinumtoxina, Botulinum toxin type a, TrenibotulinumtoxinePhase 2Not yet recruitingProject Skin MDNov 6, 2026
      Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris.Abobotulinumtoxina, Daxibotulinumtoxina, Onabotulinumtoxina, Botulinum toxin type aPhase 3Not yet recruitingCairo UniversityNov 5, 2026
      Extracorporeal Shockwave Therapy as an Additional Treatment for Spasticity Secondary to Spinal Cord InjuryBotulinum toxin type aPhase 2RecruitingKessler FoundationOct 26, 2026
      Perineural Botulinum Toxin Injection Versus Oral Duloxetine in Relief of Foot Pain in Painful Peripheral Diabetic NeuropathyAbobotulinumtoxina, Daxibotulinumtoxina, Onabotulinumtoxina, Botulinum toxin type aPhase 2Not yet recruitingAssiut UniversityOct 20, 2026
      Cleft Lip Scarring After BotoxAbobotulinumtoxina, Daxibotulinumtoxina, Onabotulinumtoxina, Botulinum toxin type aPhase 2RecruitingChildren's National Research InstituteOct 19, 2026
      MRI Study of OnabotulinumtoxinA (OnabotA) Effect on Jaw Muscle PainAbobotulinumtoxina, Daxibotulinumtoxina, Onabotulinumtoxina, Botulinum toxin type aPhase 2Not yet recruitingWeill Medical College of Cornell UniversityOct 16, 2026
      Decision Regret Following Yonsei-Point Botulinum Toxin for Gummy SmileAbobotulinumtoxina, Daxibotulinumtoxina, Incobotulinumtoxina, Onabotulinumtoxina, Botulinum toxin type a—Not yet recruitingCairo UniversityOct 14, 2026
      Can Adjunctive Oral Magnesium Supplementation Prolong the Effect of Botulinum Toxin Type A in Excessive Gingival Display?Abobotulinumtoxina, Daxibotulinumtoxina, Incobotulinumtoxina, OnabotulinumtoxinaNot applicableEnrolling by invitationCairo UniversityOct 14, 2026
      To Evaluate HU-045 With Moderate to Severe Glabellar LinesIncobotulinumtoxinaPhase 3RecruitingHuons BiopharmaOct 13, 2026
      A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial LinesTrenibotulinumtoxinePhase 2RecruitingAbbVieOct 13, 2026
      Clinical Evaluation of Botulinum Toxin a in the Management of Temporomandibular Myofascial PainIncobotulinumtoxinaPhase 2RecruitingRiphah International UniversitySep 29, 2026
      Does Addition of Medial Pterygoid Muscle Injection Improve the Outcome of Botulinum Toxin Therapy for Masticatory Myofascial Pain Syndrome?IncobotulinumtoxinaNot applicableNot yet recruitingFayoum UniversityAug 19, 2026
      A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult ParticipantsTrenibotulinumtoxinePhase 2Active, not recruitingAbbVieJul 28, 2026
      Extracorporeal Shock Wave Therapy in Botulinum Toxin-Treated Patients With Post-Stroke Ankle Plantar Flexor SpasticityIncobotulinumtoxinaNot applicableNot yet recruitingPamukkale UniversityJul 10, 2026
      Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle SyndromeIncobotulinumtoxinaPhase 2Not yet recruitingCentre Hospitalier Universitaire de NīmesJun 3, 2026
      Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder SymptomsIncobotulinumtoxina—Active, not recruitingTaksim Egitim ve Arastirma HastanesiApr 28, 2026
      BoTox Into the Sternocleidomastoid Muscles (SCM)Prabotulinumtoxin aPhase 4RecruitingBoston Medical CenterApr 1, 2025

      Diseases most associated with it

      Open Targets association score, 0 to 1; all associations
      Congenital myasthenic syndrome
      0.69
      Benign essential blepharospasm
      0.54
      Spasticity
      0.53
      Skin aging
      0.53
      Botulism
      0.51
      Urgency urinary incontinence
      0.51
      Developmental and epileptic encephalopathy
      0.50
      Hereditary disease
      0.46
      Seizure
      0.44

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364159, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P60880, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.